Evidence map›Paper›PMID 29439988›Full record

ArticleApplied and environmental microbiology2018

Display of Recombinant Proteins on Bacterial Outer Membrane Vesicles by Using Protein Ligation.

H Bart van den Berg van Saparoea, Diane Houben, Marien I de Jonge, Wouter S P Jong, Joen Luirink

Open access · bronzeAbstract read
In one paragraph

Article in Applied and environmental microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 66 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Microorganisms · 2026
    Review
  6. Review
  7. Review
  8. Revealing Cell Envelope Heterogeneity in Two StableInternational journal of molecular sciences · 2026
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Overproduction of β-barrel outer membrane proteins inExtracellular vesicles and circulating nucleic acids · 2025
    Article
  16. Intranasal delivery ofHuman vaccines & immunotherapeutics · 2024
    Article
  17. Genetically surface-modifiedBiotechnology reports (Amsterdam, Netherlands) · 2024
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

H Bart van den Berg van SaparoeaAbera Bioscience AB, Stockholm, Sweden.ORCID 0000-0003-3337-5506
Diane HoubenDepartment of Molecular Cell Biology, Section Molecular Microbiology, Faculty of Science, VU University, Amsterdam, The Netherlands.
Marien I de JongeSection of Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Wouter S P JongAbera Bioscience AB, Stockholm, Sweden.
Joen LuirinkAbera Bioscience AB, Stockholm, Sweden s.luirink@vu.nl.
Abera Bioscience (Sweden) · SERadboud University Nijmegen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The

Indexed as

Bacterial ProteinsBiotechnologyEscherichia coliMembrane ProteinsRecombinant ProteinsSalmonella typhimuriumBacterial ProteinsMembrane ProteinsRecombinant Proteinsantigen displayautodisplaynanobodyouter membrane vesicleprotein ligationSpyTagvaccine

Identifiers

PMID29439988
PMCPMC5881043
OpenAlexW2790422100

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.